First New Prescription Obesity Drug in 13 Years Wins FDA Approval
June 27, 2012 — June 27, 2012 — The Food and Drug Administration announced its approval of lorcaserin today, paving the way for the drug to become only the second prescription obesity treatment available to the roughly one-third of American who have the condition.
